Inflammatory response of coronary artery disease postmenopausal women is associated with the IVS1-397T > C estrogen receptor α polymorphism

Clinical Immunology

Volumn 130, Issue 3, 2009, Pages 355-364

  Myśliwska, Jolanta ^a   Rutkowska, Aleksandra ^a,b   Hak, Łukasz ^a   Siebert, Janusz ^a   Szyndler, Krzysztof ^a   Rachoń, Dominik ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b POSTGRADUATE SCHOOL OF MOLECULAR MEDICINE   (Poland)

Author keywords

CAD; IVS1 397T > C polymorphism; Post CABG complications; Women

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; ESTROGEN RECEPTOR ALPHA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ADVERSE OUTCOME; AGED; ANGINA PECTORIS; ARTICLE; BIOASSAY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MONOCYTE; POSTMENOPAUSE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

AGED; ANTIGENS, CD14; CELLS, CULTURED; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; ESTROGEN RECEPTOR ALPHA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MIDDLE AGED; MONOCYTES; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RECEPTORS, IGG; REFERENCE STANDARDS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 59349119868     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.09.017     Document Type: Article

References (57)

1. Tedgui A., and Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 86 (2006) 515-581
2. Hanson G.K. Immune mechanisms in atherosclerosis. ATVB 21 (2001) 1876-1890
3. Mobley J.L., Leininger M., Madore S., Baginski T.J., and Renkiewicz R. Genetic evidence of a functional monocyte dichotomy. Inflammation 30 (2007) 189-197
4. Steppich B., Dayyani F., Gruber R., Lorenz R., Mack M., and Ziegler-Heitbrock H.W. Selective mobilization of CD14(+)CD16(+) monocytes by exercise. Am. J. Physiol. Cell Physiol. 279 (2000) C578-C586
5. Belge K.U., Dayyani F., Horelt A., Siedlar M., Frankenberger M., Frankenberger B., Espevik T., and Ziegler-Heitbrock L.J. The proinflammatory CD14+CD16+Dr++ monocytes are a major source of TNF. J. Immunol. 168 (2002) 3536-3542
6. Frankenberger M., Sternsdorf T., Pechumer H., Pforte A., and Ziegler-Heitbrock H.W. Differential cytokine expression in human blood monocyte subpopulation: a polymerase chain reaction analysis. Blood 87 (1996) 373-377
7. ++ blood monocyte subsets. Clin. Exp. Immunol. 123 (2001) 49-55
8. Szaflarska A., Baj-Krzyworzeka M., Siedlar M., Weglarczyk K., Ruggiero I., Hajto B., Zembala M., and M. Antitumor response of CD14+/CD16+ monocyte subpopulation. Exp. Hematol. 32 (2004) 748-755
9. Ancuta P., Wang J., and Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1-expressing endothelial cells. J. Leukoc. Biol. 80 (2006) 1156-1164
10. Ziegler-Heitbrock L. The CD14+CD16+ blood monocytes: their role in infection and inflammation. J. Leukoc. Biol. 81 (2007) 584-592
11. Ancuta P., Weiss L., and Haeffner-Cavaillon N. CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics. Eur. J. Immmunol. 30 (2000) 1872-1883
12. Okamoto H., Mizuno K., and Horio T. Circulating CD14+CD16+ monocytes are expanded in sarcoidosis patients. J. Dermatol. 30 (2003) 503-509
13. Fingerle G., Pforte A., Passlick B., Blumenstein M., Ströbel M., and Ziegler-Heitbrock H.W. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82 (1993) 3170-3176
14. Ramirez R., Carracedo J., Berdud L., Carretero D., Merino A., Rodríguez M., Tetta C., Martín-Malo A., and Aljama P. Microinflammation in hemodialysis is related to a preactivated subset of monocytes. Hemodial. Int. 10 Suppl 1 (2006) S24-S27
15. Cairns A.P., Crockard A.D., and Bell A.L. The CD14 + CD16 + monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol. Int. 21 (2002) 189-192
16. Schlitt A., Heine G.H., Blankenberg S., Espinola-Klein C.H., Dopheide J.F., Bickel C.H., Lackner K.J., Iz M., Meyer J., Darius H., and Rupprecht H.J. CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-α levels. Thromb. Haemost. 92 (2004) 419-424
17. Shaw L.J. New insights into ischemic heart disease in women. Cleveland Clin. J. Med. 74 (2007) 585-594
18. Saltiki K., and Alevizaki M. Coronary heart disease in postmenopausal women; the role of endogenous estrogens and their receptors. Hormones (Athens) 6 (2007) 9-24
19. Matthews K.A., Santoro N., Lasley B., Chang Y., Crawford S., Pasternak R.C., Sutton-Tyrrell K., and Sowers M. Relation of cardiovascular risk factors in women approaching menopause to menstrual cycle characteristics and reproductive hormones in the follicular and luteal phases. J. Clin. Endocrinol. Metab. 91 (2006) 1789-1795
20. Matthews K.A., Meilahn E., Kuller L.H., Kelsey S.F., Caggiula A.W., Wing R.R., and R.R. Menopause and risk factors for coronary heart disease. N. Engl J. Med. 321 (1989) 641-646
21. Carr M.C. The emergence of the metabolic syndrome with menopause. J. Clin. Endocrinol. Metab. 88 (2003) 2404-2411
22. Mudali S., Dobs A.S., Ding J., Cauley J.A., Szklo M., and Golden S.H. Atherosclerosis risk in communities study. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J. Clin. Endocrinol. Metab. 90 (2005) 1202-1209
23. Saltiki K., Doukas C., Kanakakis J., Anastasiou E., Mantzou E., and Alevizaki M. Severity of cardiovascular disease in women: relation with exposure to endogenous estrogen. Maturitas 55 (2006) 51-57
24. Rexrode K.M., Ridker P.M., Hegener H.H., Buring J.E., Manson J.E., and Zee R.Y. Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin. Chem. 53 (2007) 1749-1756
25. Domingues-Montanari S., Subirana I., Tomás M., Marrugat J., and Sentí M. Association between ESR2 genetic variants and risk of myocardial infarction. Clin. Chem. 54 (2008) 1183-1189
26. Lawlor D.A., Timpson N., Ebrahim S., Day I.N., and Smith G.D. The association of oestrogen receptor alpha-haplotypes with cardiovascular risk factors in the British Women's Heart and Health Study. Eur. Heart J. 27 (2006) 1597-1604
27. Rokach A., Pollak A., Rosen L., Friedlander Y., Blumenfeld A., Reznik L., and Dresner-Pollak R. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J. Clin. Endocrinol. Metab. 90 (2005) 6556-6560
28. Deng H.W., Li J., Li J.L., Dowd R., Davies K.M., Johnson M., Gong G., Deng H., and Recker R.R. Association of estrogen receptor-alpha genotypes with body mass index in normal healthy postmenopausal Caucasian women. J. Clin. Endocrinol. Metab. 85 (2000) 2748-2751
29. Schuit S.C., van Meurs J.B.J., Bergink A.P., van der Klift M., Fang Y., Leusink G., Hofman A., van Leeuwen J.P., Uitterlinden A.G., and Pols H.A. Height in pre-and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J. Clin. Endocrinol. Metab. 89 (2004) 303-309
30. van Meurs J.B., Schuit S.C., Weel A.E., van der Klift M., Bergink A.P., Arp P.P., Colin E.M., Fang Y., Hofman A., van Duijn C.M., van Leeuwen J.P., Pols H.A., and Uitterlinden A.G. Association of 5′ estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum. Mol. Genet. 12 (2003) 1745-1754
31. Weel A., Uitterlinden A.G., Westendorp I.C.D., Burger H., Schuit S.C.E., Hofman A., Helmerhorst T.J.M., van Leeuwen J.P.T.M., and Pols H.A.P. Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. J. Clin. Endocrinol. Metab. 84 (1999) 3146-3150
32. Shearman A.M., Cooper J.A., Kotwinski P.J., Miller G.J., Humphries S.E., Ardlie K.G., Jordan B., Irenze K., Lunetta K.L., Schuit S.C.E., Uitterlinden A.G., Pols H.A.P., Demissie S., Cupples A., Mendelsohn M.E., Levy D., and Hausman D.E. Estrogen receptor α gene variation is associated with risk of myocardial infarction in more than seven thousand men from five cohorts. Circulation Res. 98 (2006) 590-592
33. Almeida S., and Hutz M.H. Estrogen receptor 1 gene polymorphisms and coronary artery disease in the Brazilian population. Braz. J. Med. Biol. Res. 39 (2006) 447-454
34. Rokach A., Pollak A., Rosen L., Friedlander Y., Blumenfeld A., Reznik L., and Dresner-Pollak R. Estrogen receptor alpha gene polymorphisms are associated with the angiographic extent of coronary artery disease. J. Clin. Endocrinol. Metab. 90 (2005) 6556-6560
35. Lehtimäki T., Kunnas T.A., Mattila K.M., Perola M., Penttilä A., Koivula T., and Karhunen P.J. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J. Mol. Med. 80 (2002) 1432-1440
36. Shearman A.M., Cooper J.A., Kotwinski P.J., Humphries S.E., Mendelsohn M.E., Housman D.E., and Miller G.J. Estrogen receptor α gene variation and the risk of stroke. Stroke 36 (2005) 2281-2282
37. Myśliwska J., Wieckiewicz J., Hak L., Siebert J., Rogowski J., Szyndler K., and Myśliwski A. Interleukin 6 polymorphism corresponds to the number of severely stenosed coronary arteries. Eur. Cyt. Netw. 17 (2006) 181-188
38. Schuit S.C., Oei H.H., Witteman J.C., Geurts van Kessel C.H., van Meurs J.B., Nijhuis R.L., van Leeuwen J.P., de Jong F.H., Zillikens M.C., Hofman A., Pols H.A., and Uitterlinden A.G. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
39. Ferrero V., Ribichini F., Matullo G., Guarrera S., Carturan S., Vado A., Vassanelli C., Piazza A., Uslenghi E., and Wijns W. Estrogen receptor-alpha polymorphisms and angiographic outcome after coronary artery stenting. ATVB 23 (2003) 2223-2228
40. Nordström P., Glader C.A., Dahlén G., Birgander L.S., Lorentzon R., Waldenström A., and Lorentzon M. Oestrogen receptor α gene polymorphism is related to aortic valve sclerosis in postmenopausal women. J. Int. Med. 254 (2003) 140-146
41. Herrington D.M., Howard T.D., Brosnihan K.B., McDonnell D.P., Li X., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., Meyers D.A., and Bleecker E.R. Common estrogen receptor polymorphism augments effects of hormone replacement therapy on E-selectin but not C-reactive protein. Circulation 105 (2002) 1879-1882
42. Herrington D.M., Howard T.D., Hawkins G.A., Reboussin D.M., Xu J., Zheng S.L., Brosnihan K.B., Meyers D.A., and Bleecker E.R. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New England J. Med. 346 (2002) 967-974
43. Rapuri P.B., Gallagher J.C., Knezetic J.C., and Haynatzka V. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen. Maturitas 53 (2006) 371-379
44. Emre A., Sahin S., Erzik C., Nurkalem Z., Oz D., Cirakoglu B., Yesilcimen K., and Ersek B. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease. Cardiology 106 (2006) 44-50
45. Pfeilshifter J., Köditz R., Pfohl M., and Schatz H. Changes in proinflammatory cytokine activity after menopause. Endocr. Rev. 23 (2002) 90-119
46. Rachoń D., Myśliwska J., Suchecka-Rachoń K., Wie{ogonek}ckiewicz J., and Myśliwski A. Effects of oestrogen deprivation on interleukin-6 production by peripheral blood mononuclear cells of postmenopausal women. J. Endocrinol. 172 (2002) 387-395
47. Rachoń D., Suchecka-Rachoń K., Hak L., and Myśliwska J. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women. Menopause 5 (2006) 840-845
48. Liu H., Liu K., and Bodenner D.L. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor kappa B transactivation. Cytokine 31 (2005) 251-257
49. Ghisletti S., Meda C., Maggi A., and Vegeto E. 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappa B intracellular localization. Mol. Cell. Biol. 25 (2005) 2956-2968
50. Kramer P.R., Winger V., and Kramer S.F. 17β-estradiol utilizes the estrogen receptor to regulate CD16 expression in monocytes. Mol. Cell. Endocrinol. 279 (2007) 16-25
51. Ben-Hur H., Mor G., Insler V., Blickstein I., Amir-Zaltsman Y., Sharp A., Globerson A., and Kohen F. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. A.M.J. Reprod. Immunol. 34 (1995) 363-369
52. Shcuit S.C., Oei H.H., Witteman J.C., Geurts van Kessel C.H., van Meurs J.B., Nijhuis R.L., van Leeuwen J.P., de Jong F.H., Zillikens M.C., Hofman A., Pols H.A., and Uitterlinden A.G. Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 291 (2004) 2969-2977
53. Koch W., Hoppmann P., Pfeufer A., Mueller J.C., Schömig A., and Kastrati A. No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation 112 (2005) 2138-2142
54. Schuit S.C.E., de Jong F.H., Stolk L., Koek W.N., van Meurs J.B., Schoofs M.W., Zillikens M.C., Hofman A., van Leeuwen J.P., Pols H.A., and Uitterlinden A.G. Estrogen receptor alpha gene polymorphisms are associated with estradiol levels in postmenopausal women. Eur. J. Endocrinol. 153 (2005) 327-334
55. Yamada K., Havashi T., Kuzuya M., Naito M., Asai K., and Iguchi A. Physiological concentration of 17 beta-estradiol inhibits chemotaxis of human monocytes in response to monocyte chemotactic protein 1. Artery 22 (1996) 24-35
56. Nilsson B.O. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm. Res. 56 (2007) 269-273
57. Squadrito F., Altavilla D., Squadrito G., Campo G.M., Arlotta M., Arcoraci V., Minutoli L., Serrano M., Saitta A., and Caputi A.P. 17Beta-oestradiol reduces cardiac leukocyte accumulation in myocardial ischaemia reperfusion injury in rat. Eur. J. Pharmacol. 24 (1997) 185-192